I am delighted to have the opportunity to comment on the article, “Research progress on icariin, a traditional Chinese medicine extract, in the treatment of asthma "by Jia-Ying Yuan et al. Current asthma management guidelines recommend inhaled glucocorticoids as preferred therapy for control of mild persistent, moderate and severe asthma, according to the Global Initiative for Asthma (GINA) guidelines . However, hormonal imbalance can lead to several health issues such as obesity, cardiovascular disease, autoimmune disease, breast cancer, and osteoporosis.It is an important research direction to find new, safe and effective drugs to replace hormones in the treatment of asthma.Traditional Chinese medicines and natural medicine are getting more attention, since Tu Youyou was awarded the 2015 Nobel Prize in physiology or medicine for the discovery of artemisinin used for malaria treatment. Epimedium for the treatment of asthma has been proposed in various traditional Chinese medicine prescriptions. Epimedium herb, commonly named as Yinyanghuo in Chinese, has its origins in the Berberidaceae family which include Epimedium koreanum Nakai, Epimedium brevicornum Maxim, Epimedium pubescens Maxim and Epimedium sagittatum. Icariin is a major bioactive component extracted from Epimediumbrevicornum Maxim, which has various biological attributessuch as anti-inflammatory and antioxidative activities, and immune regulation.
As we all know, the pathogenesis of asthma is complex. Airway inflammation and airway remodeling are the main characteristics of asthma.Through a large number of literature collection, the author found that icariin mainly treats asthma through the following mechanisms:One ofthe mechanismis that Icariin could inhibit airway inflammation by regulating the expression of eosinophils and basophils and the Hypothalamic–Pituitary–Adrenal Axis (HPAA), improving the imbalance of Th1/Th2 cell and Th17/Treg cells and inhibiting the expression of Prostaglandin D2 (PGD2) and Endoplasmic Reticulum (ER) stress. The other mechanism is thatIcariin could inhibit airway remodeling byinhibiting extracellular matrix (ECM) deposition, airway epithelial cell-to-Mesenchymal Transition (EMT), airway smooth muscle (ASMC) proliferation and the proinflammatory effect of macrophages. There are many mechanisms of icariin in the treatment of asthma, butwhich mechanism is the most important is still worth further study.
Icariin has attracted extensive attention in clinical treatment because of its extensive role.In this article, the author proposes that icariin has been found in many articles to have a variety of functions and is widely used in the treatment of various diseases,including lung cancer, heart disease, osteoporosis, and rheumatism [2-5]. It also can be used for the treatment of rheumatism and amelioration of neurological deficts [6,7]. Whether icariin will become a panacea like aspirin, or will it be combined with other traditional Chinese medicine to have many therapeutic effects on other diseases, which is also worthy of in-depth exploration and research.
Citation: Yu K, Zhao J-Y (2022) Commentary on Jia-Ying Yuan et al.: Research Progress on Icariin, a Traditional Chinese Medicine Extract, in the Treatment of Asthma. J Altern Complement Integr Med 8: 223.
Copyright: © 2022 Kai Yu, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.